PREDICTIVE FACTORS FOR PERIOPERATIVE TREATMENTS IN BLADDER CARCINOMA

Muscle-invasive bladder carcinoma (MIBC) has been classified into transcriptomic subtypes, but proteomics studies remain scarce. Fifty-eight paraffin-embedded MIBC samples obtained atransurethral resection (prior to treatment) and at the cystectomy (after neoadjuvant treatment) were analyzed for protein extraction and proteomics profiling by DIA-MS.